Lessee, Operating Lease, Liability, to be Paid, Year Two of Edesa Biotech, Inc. from 31 Mar 2023 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Edesa Biotech, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Mar 2023 to 31 Mar 2024.
  • Edesa Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Mar 2024 was $19,978, a 0.1% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $19,978 -$19 -0.1% 31 Mar 2024 10-Q 10 May 2024 2024 Q2
Q4 2023 $20,411 31 Dec 2023 10-Q 09 Feb 2024 2024 Q1
Q3 2023 $19,924 30 Sep 2023 10-K 15 Dec 2023 2023 FY
Q2 2023 $20,422 30 Jun 2023 10-Q 09 Aug 2023 2023 Q3
Q1 2023 $19,997 31 Mar 2023 10-Q 11 May 2023 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.